2F-QMPSB
Chemical compound
From Wikipedia, the free encyclopedia
2F-QMPSB (SGT-13) is an arylsulfonamide-based synthetic cannabinoid that is a fluorinated derivative of QMPSB and has been sold as a designer drug.[1] Its identification was first reported by a forensic laboratory in Italy in January 2019,[2] and it was made illegal in Latvia shortly afterwards.[3][4] Fluorination of the tail group is a common strategy to increase potency at cannabinoid receptors which is seen in many related series of compounds.[5][6]
Legal status
- CA: Schedule II
- DE: NpSG (Industrial and scientific use only)
- UK: Under Psychoactive Substances Act
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C22H20F2N2O4S |
| Molar mass | 446.47 g·mol−1 |
| 3D model (JSmol) | |
| |
| |